Company profile

Biosplice

Biosplice Therapeutics, founded in 2008 and headquartered in San Diego, California, United States, has raised $778 million in total funding and reached a $12 billion valuation after its $120 million Series D round in 2021. The company develops RNA splicing–based therapeutics targeting diseases such as osteoarthritis, cancer, and neurological disorders. With 175 employees, Biosplice focuses on CLK/DYRK kinase modulation to restore normal cellular function, positioning itself as a global leader in RNA-based disease treatment and regenerative medicine.

Back to profiles

Quick facts

Total funding: $778 million
Valuation: $12 billion
Founded: 2008
Headquarters: San Diego, California, United States
Employees: 175

Reach buyers like Biosplice on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like Biosplice
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like Biosplice.

The 14-day trial ships every feature, no card required.

Start free →